07630.HK
Impact Therap-b
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 15.59
+4.07%Leverage
- Debt / equity
- -0.90x
- Net debt / equity
- -0.63x
- Debt / assets
- 2.58x
- Debt / EBITDA
- -2.13x
- Net debt / EBITDA
- -1.49x
Liquidity & coverage
- Current ratio
- 3.08x
- Quick ratio
- 2.82x
- Cash ratio
- 2.47x
- Interest coverage
- -3.53x
- EBITDA / interest
- -3.36x
- Working capital
- HKD 244.7M
Cash & dividend
- FCF / debt
- -0.21x
- Cash flow / debt
- -0.21x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025